Biomimetic Therapeutics Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
75
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$293M
Biomimetic Therapeutics General Information
Description
Developer of biologically active drug-device combination products for the healing of injuries and diseases to the skeleton and associated tissues, including periodontal, orthopedic, spine and sports injury applications.
Contact Information
Website
www.biomimetics.comCorporate Office
- 389 Nichol Mill Lane
- Franklin, TN 37067
- United States
Corporate Office
- 389 Nichol Mill Lane
- Franklin, TN 37067
- United States
Biomimetic Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Mar-2013 | $293M | Completed | Profitable | ||
| 6. PIPE | 17-Apr-2009 | Completed | Profitable | |||
| 5. IPO | 12-May-2006 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 07-Jul-2005 | Completed | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC (Series B) | 30-Jun-2003 | Completed | Startup | |||
| 2. Early Stage VC (Series A2) | 01-May-2002 | $4.25M | $8.56M | Completed | Startup | |
| 1. Early Stage VC (Series A1) | 01-Jun-2001 | $4.31M | $4.31M | Completed | Startup |
Biomimetic Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | 1,026,570 | $0.001000 | $4.14 | $4.14 | 1x | $4.14 | 9.7% | |
| Series A1 | 1,137,702 | $0.001000 | $3.79 | $3.79 | 1x | $3.79 | 10.75% |
Biomimetic Therapeutics Comparisons
Industry
Financing
Details
Biomimetic Therapeutics Competitors (5)
One of Biomimetic Therapeutics’s 5 competitors is NellOne Therapeutics, a Venture Capital-Backed company based in Knoxville, TN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NellOne Therapeutics | Venture Capital-Backed | Knoxville, TN | ||||
| Kedrion | Private Equity-Backed | Barga, Italy | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Biogen | Formerly VC-backed | Cambridge, MA |
Biomimetic Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biomimetic Therapeutics Patents
Biomimetic Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025042830-A1 | Platelet-derived growth factor bone graft putty formulation | Inactive | 18-Aug-2023 | ||
| WO-2020186267-A2 | Platelet-derived growth factor formulations for enhancing bone fusion | Inactive | 14-Mar-2019 | ||
| WO-2020186267-A3 | Platelet-derived growth factor formulations for enhancing bone fusion | Inactive | 14-Mar-2019 | ||
| US-20200297897-A1 | Platelet-derived growth factor formulations for enhancing spine fusion | Inactive | 14-Mar-2019 | ||
| US-20140251978-A1 | Method for operating a glow plug, and glow plug control device | Active | 08-Mar-2013 | F02P19/025 |
Biomimetic Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biomimetic Therapeutics Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axiom Venture Partners | Venture Capital | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| HSS Ventures | Venture Capital | Minority | ||
| Holden Ventures | Venture Capital | Minority | ||
| InterWest Health Partners | Corporate Venture Capital | Majority |
Biomimetic Therapeutics FAQs
-
When was Biomimetic Therapeutics founded?
Biomimetic Therapeutics was founded in 1999.
-
Where is Biomimetic Therapeutics headquartered?
Biomimetic Therapeutics is headquartered in Franklin, TN.
-
What is the size of Biomimetic Therapeutics?
Biomimetic Therapeutics has 75 total employees.
-
What industry is Biomimetic Therapeutics in?
Biomimetic Therapeutics’s primary industry is Biotechnology.
-
Is Biomimetic Therapeutics a private or public company?
Biomimetic Therapeutics is a Private company.
-
What is the current valuation of Biomimetic Therapeutics?
The current valuation of Biomimetic Therapeutics is .
-
What is Biomimetic Therapeutics’s current revenue?
The current revenue for Biomimetic Therapeutics is .
-
How much funding has Biomimetic Therapeutics raised over time?
Biomimetic Therapeutics has raised $96.7M.
-
Who are Biomimetic Therapeutics’s investors?
Axiom Venture Partners, Burrill & Co, HSS Ventures, Holden Ventures, and InterWest Health Partners are 5 of 12 investors who have invested in Biomimetic Therapeutics.
-
Who are Biomimetic Therapeutics’s competitors?
NellOne Therapeutics, Kedrion, Genentech, Sangamo Therapeutics, and Biogen are competitors of Biomimetic Therapeutics.
-
When was Biomimetic Therapeutics acquired?
Biomimetic Therapeutics was acquired on 01-Mar-2013.
-
Who acquired Biomimetic Therapeutics?
Biomimetic Therapeutics was acquired by Wright Medical Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
